The burden trend and risk factors of multiple myeloma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Wang, C.; Guo, Y.; Wang, N.; Ren, Q.; Xu, Y.; Lu, S.; Zou, Y.; Li, R.; Wang, J.; Yuan, L.; She, W.; Tian, H.; Bi, S.; Guo, X.; Ma, Y.; Sun, H.; Zhang, C.; Dong, Y.; Shang, Z.; Lv, H.; Lv, W.; Zhang, M.; Jiang, Y.
Show abstract
IMPORTANCEMM was an incurable clonal plasma cell malignancy with substantial prevalence and incidence, which had resulted in a significant burden of disease. Our study aimed to evaluate the global, regional and national burden of MM by sex, age, and SDI from 1990 to 2021, along with associated risk factors and predicted temporal trends. OBJECTIVETo assess the global burden, epidemiological trends, and risk factors of MM and project its incidence rate by 2050. DesignThis is a systematic analysis of the global burden of MM from 1990 to 2021. SettingThe study primarily analyzed the prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of MM from Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2021, by region, age, sex, and SDI. ParticipantsThe study builds on findings from the GBD 2021. ExposureMultiple myeloma. Main Outcomes and MeasuresThe Joinpoint regression was used to describe the trends. Two-sample Mendelian randomization (MR) analysis was conducted to identify the causal relationship between weight-related risk factors and MM. The Bayesian age-period-cohort (BAPC) model was used to predict the future trend. ResultsIn 2021, the age-standardized prevalence rate (ASPR) of MM was 4.65 (95% UI: 4.21 to 5.01) per 100,000 people, and the age-standardized mortality rate (ASMR) was 1.40 (95% UI: 1.24 to 1.52) per 100,000 people globally. The burden of MM was the highest in the high SDI region, with Monaco and Bahamas reporting the highest age-standardized incidence rate (ASIR), age-standardized DALY rate (ASDR), and ASMR in 2021. Simultaneously, ASRs peaked in the elderly population and were higher in males than in females. GBD 2021 reported high body mass index (BMI) as a risk factor for MM which was further confirmed by two-sample MR analysis. Additionally, BMI, waist circumference, obesity class 1, obesity class 2, overweight and hip circumference were also risk factors for MM. By 2050, the global incidence rate was predicted to decrease slightly but increase within the age group of 20-69. Conclusions and RelevanceThis study found that MM remained a significant public health issue, particularly in high SDI regions and among the elderly. A causal relationship exists between MM and body weight, indicating the need for targeted prevention and intervention strategies in high-risk regions and populations.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study 87%
- Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study 87%
- Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region 85%
Similar papers in this journal
- Single-cell Sequencing Highlights Heterogeneity and Malignant Progression in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma 90%
- Molecular Feature-Based Classification of Retroperitoneal Liposarcoma: A Prospective Cohort Study 90%
- Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients 90%
Similar papers in this journal
- Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China 90%
- Deciphering the Role of Complement System Genes in Pancreatic Cancer Susceptibility and Prognosis 89%
- Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan 89%
Similar papers in this journal
- Association of inflammatory markers with the severity of COVID-19 88%
- Epidemiological characteristics of 1212 COVID-19 patients in Henan, China 88%
- Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.